Quantitative Systematic Strategies LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
SELL
$61.35 - $90.47 $318,161 - $469,177
-5,186 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$43.82 - $85.37 $227,250 - $442,728
5,186 New
5,186 $398,000
Q3 2018

Nov 14, 2018
SELL
$14.0 - $20.3 $173,936 - $252,207
-12,424 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$6.37 - $14.02 $9,599 - $21,128
-1,507 Reduced 10.82%
12,424 $169,000
Q1 2018

May 04, 2018
BUY
$3.72 - $7.64 $51,823 - $106,432
13,931 New
13,931 $100,000

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
92.3M
Call Options Held
1.33M
Put Options Held
549K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email